Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Kingswood buys wealth manager; Helios capacity grows

Mon, 15th Nov 2021 19:13

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Kingswood Holdings Ltd - London-based wealth manager - Agrees to acquire Money Matters Ltd, a privately owned wealth management business, primarily offering its services in the North East of England, for total cash consideration of GBP3.4 million, paid over 2 years. Notes GBP1.7 million will be paid immediately, with further GBP1.7 million paid on achievement of performance targets. Money Maters North East business holds about GBP115 million assets under administration from about 600 clients. Kingswood's UK CEO David Lawrence says: "We remain committed to perpetuating our stated growth strategy within the UK and internationally. This is our second acquisition of 2021 and we continue to have a strong pipeline of high-quality UK opportunities under negotiation, six of which are in exclusive due diligence as we continue to grow our financial planning and investment management reach across the UK. We expect to be making more announcements over the coming weeks.''

----------

Schroder Real Estate Investment Trust Ltd - invests in UK commercial real estate, seeking income and capital growth from active management - Exchanges or completes 13 new lettings, renewals and reviews which will generate GBP300,000 per annum of rental income and increase contracted rental income by GBP185,000 per annum since September 20. Notes set to deliver 80,000 square foot of operationally net zero carbon industrial, storage and distribution space at Stanley Green Trading Estate after receipt of a resolution to grant planning permission.

----------

Helios Underwriting PLC - London-based investment vehicle, which acquires and consolidates underwriting capacity at Lloyd's - Notes December 31 expected capacity value to rise to GBP60.2 million from GBP30.8 million a year earlier. Expecting to acquire 29 LLVs during 2021 with capacity of GBP35.4 million, which was valued at 2021 capacity prices at GBP18.0 million. Chief Executive Nigel Hanbury says: "I am delighted that the value of the capacity portfolio will increase to GBP60 million with the revaluation of the existing portfolio adding 9.6p to the tangible net asset value per share - a 6.6% increase." Company adds: "Helios continued to manage the capacity portfolio discarding unwanted syndicates and taking positions on syndicates, in particular syndicate 510 and syndicate 2689, taking the total additional capacity acquired at auction to GBP23.8 million for consideration of GBP2.6 million."

----------

Thalassa Holdings Ltd - British Virgin Islands-based investment company in real estate, fintech and robotics - Subsidiary id4 delivers "client space solution" to Swiss-based asset manager Geneva Management Group. "The id4 client space solution, delivered using cloud-based technology, will enable GMG to onboard clients remotely and to review KYC profiles periodically," company says.

----------

Insig AI PLC - London-based machine learning and data science firm serving asset management industry, formerly known as Catena - Signs proof of concept exercise with unnamed European asset manager with assets under management of several billion euros. "In this initial proof-of-concept exercise on one of the client's larger funds, valued in excess of EUR1 billion, Insig AI has been tasked to use its machine learning data and expertise to analyse and categorise the client's portfolio," company says.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - US partner Eton Pharmaceuticals signs co-promotion deal for Alkindi Sprinkle with Tolmar Pharmaceuticals. As part of deal, Tolmar's 62-person sales force will promote Alkindi Sprinkle to their paediatric endocrinology targets alongside its own existing product. "Eton has indicated that it expects the co-promotion agreement to translate to significantly faster adoption of Alkindi Sprinkle and to accelerate the time to reach peak conversion of patients from existing therapy. The terms of Diurnal's licensing agreement with Eton are unaffected by Eton's agreement with Tolmar," Diurnal says.

----------

Panthera Resources PLC - gold exploration and development company with assets in West Africa and India - Settles agreements with Metal Mining India Private Ltd to buy its Indian joint venture partner for AUD1.8 million, just under GBP1 million. Issues 3.0 million shares and pays GBP500,000 to close deal. Notes ownership interest in the Bhukia and Taregaon projects in India via IGL has increased to 100%, giving Panthera a 95% interest, if prospecting licences are granted in the future.

----------

Mkango Resources Ltd - Vancouver-based explorer for rare earth elements - German subsidiary HyProMag Ltd creates new business HyProMag GmbH alongside Pforzheim University professor Carlo Burkhardt. HyProMag will own 80% of new business, while Burkhardt will take own remaining 20%. "Germany is a major producer and market for rare earth magnets in Europe, and the establishment of HyProMag GmbH provides a strong platform to grow the business in the region. Germany has no domestic sources of primary rare earths. Development of domestic sources of recycled rare earths via the patented HPMS is a significant opportunity to diversify and strengthen development of a more resilient rare earths supply chain in Europe," company explains.

----------

W Resources PLC- tungsten, tin and gold mining and exploring in Spain and Portugal - Raises GBP750,000 from placing 12.5 million shares at 6 pence each. "Following the award of the mining licence at the Régua tungsten mine in Portugal, the majority of the funds raised from the placing will be used to progress the mine development and to accelerate the environmental impact study report this quarter, as the team works towards first production in the second half of 2022," company says. Notes it will also use part of the funds at the La Parrilla mine in Spain to improve the laboratories, finished goods warehouse and spare parts warehouse. Enlarged share capital now 133.1 million.

----------

Bradda Head Lithium Ltd - Isle of Man-based exploration and mining services provider - Signs binding letter of intent for royalty agreement with Lithium Royalty Corp for 2% gross overriding royalty for sedimentary lithium claims in central Arizona. Value of agreement worth USD8 million. Notes USD2.5 million will be paid on closing of deal, USD2.5 million will be paid after Bradda obtains 1 million tonnes lithium carbonate equivalent; and finally, USD3 million to be paid after Bradda obtains 2.5 million tonnes lithium. Chief Executive Charles FitzRoy says: "We are delighted that Lithium Royalty Corporation has chosen to partner with us. This agreement further endorses the confidence in and inherent value that we believe our assets have; as well as in the future potential of the Company and our strategy given LRC's investment in Bradda."

----------

Chaarat Gold Holdings Ltd - gold miner in Armenia and mine developer in Kyrgyz Republic - Chief Financial Office Chris Eger to leave firm on November 30. Company says CFO will "pursue other opportunities". "Chris leaves with the board's appreciation and thanks for the role he has played in the development of Chaarat over the last three years," company adds. Starts search for replacement, and says current management team will assume Eger's responsibilities.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Jul 2018 09:39

IP Group Swings To Loss In First-Half On Reduction In Portfolio Gains

LONDON (Alliance News) - IP Group PLC on Wednesday said it saw a swing to loss in the first half of 2018 despite an improvement in its portfolio valuation.The intellectual property-based to

Read more
18 Jun 2018 16:22

Abcam Appoints Former Celltech CFO As Non-Executive Chairman

LONDON (Alliance News) - Life sciences company Abcam PLC said Monday it has appointed the former chief financial officer of Celtech Group PLC as a non-executive chairman.Peter Allen is a at

Read more
3 Apr 2018 16:19

Diurnal To Raise GBP10.5 Million Via Share Placing (ALLISS)

LONDON (Alliance News) - Diurnal Group PLC said on Tuesday that it intends to raise GBP10.5 million through the placing of different types of shares.The

Read more
20 Mar 2018 18:28

Diurnal Nets GBP500,000 From Broker Option Exercise (ALLISS)

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC on Tuesday said that it has received a letter of notice to exercise the broker option in respect of 263,157 in

Read more
12 Mar 2018 13:51

UPDATE: Diurnal Prepares For First Revenue As Appoints Trial Partner

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC on Monday appointed a clinical trial services provider for its Chronocort treatment, as it posted a widened loss

Read more
12 Mar 2018 10:18

Diurnal Interim Loss Widens On Cost Rise As Prepares For First Revenue

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC said Monday its interim loss widened amid a rise in research and administrative expenses, as it prepares to its

Read more
12 Mar 2018 05:17

UK Stocks-Factors to watch on March 12

March 12 (Reuters) - Britain's FTSE 100 index is seen opening up 8 points higher at 7,233 on Monday, according to financial bookmakers. * GKN-MELROSE: GKN has struck a deal

Read more
25 Jan 2017 09:31

Diurnal Agrees Two Deals With UDG Healthcare Ahead Of Infacort Launch

Read more
17 Jan 2017 15:43

DIRECTOR DEALINGS: Diurnal Non-Executive Ups Interest

Read more
16 Jan 2017 15:08

Director dealings: Diurnal trio dip in after EMA submission in December

(ShareCast News) - A trio of Diurnal Group directors bought shares in the hormone disease specialist, which remain little higher than the low reached late last year. Chairman Peter Allen bought 40,000 shares at 105p and non-executive directors Sam Williams and John Goddard bought 9,248 each at a pri

Read more
12 Jan 2017 09:04

Diurnal Hires Outgoing Mereo BioPharma Finance Chief Bungay

Read more
20 Dec 2016 12:23

Diurnal Submits European Marketing Application For Infacort

Read more
21 Nov 2016 09:32

Diurnal Doses First Testosterone Replacement Therapy Trial Patients

Read more
5 Oct 2016 15:09

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
11 Jul 2016 08:00

Diurnal and IP Group eye 2017 launch for childhood hormonal treatment

(ShareCast News) - Diurnal Group, 45%-owned by university spin-out specialist IP Group, has produced positive clinical trial results for its treatment for a rare hormonal disease in young children. A European Phase III study for AIM-quoted Diurnal's Infacort treatment for paediatric Adrenal Insuffic

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.